Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 1:98:43-51.
doi: 10.1016/j.placenta.2020.01.015. Epub 2020 Jan 31.

Exploring the causes and consequences of maternal metabolic maladaptations during pregnancy: Lessons from animal models

Affiliations
Review

Exploring the causes and consequences of maternal metabolic maladaptations during pregnancy: Lessons from animal models

Amanda N Sferruzzi-Perri et al. Placenta. .

Abstract

Pregnancy is a remarkable physiological state, during which the metabolic system of the mother adapts to ensure that nutrients are made available for transfer to the fetus for growth and development. Adaptations of maternal metabolism during pregnancy are influenced by the metabolic and nutritional status of the mother and the production of endocrine factors by the placenta that exert metabolic effects. Insufficient or inappropriate adaptations in maternal metabolism during pregnancy may lead to pregnancy complications with important short- and long-term effects for both the health of the child and mother. This is very evident in gestational diabetes, which is marked by greater glucose intolerance and insulin resistance above that expected of a normal pregnancy. Gestational diabetes is associated with increased fetal weight and/or increased adiposity, higher instrumented delivery rates and greater risks for both mother and child of developing type 2 diabetes in the long-term. However, despite the negative health impacts of such metabolic imbalances during pregnancy, the precise mechanisms responsible for orchestrating these changes remain largely unknown. The present review describes the dynamic pregnancy-specific changes that occur in the metabolic system of the mother during pregnancy. It also discusses findings using surgical, pharmacological, genetic and dietary methods in experimental animals that highlight the role of pathways in maternal tissues that lead to metabolic dysfunction, with a particular focus on gestational diabetes. Finally, it summarises the work largely employing gene targeting and hormone administration in rodents that have illuminated the involvement of placental endocrine function in driving maternal metabolic adaptations. While current animal models may not fully replicate what is observed in humans, these have been instrumental in showing that there is a dynamic interplay between changes in maternal metabolic physiology and the placental production of endocrine factors that govern the availability of nutrients to the growing fetus. However, more work is required to specifically identify the placenta-driven changes in maternal metabolic physiology that ensure the appropriate level of insulin production and action during pregnancy. In doing so, these studies may pave the way to understanding the development of pregnancy complications like gestational diabetes, as well as further our understanding of type-2 diabetes and the control of metabolic physiology more broadly.

Keywords: Fetal growth; Gestational diabetes; Hormones; Metabolism; Nutrient partitioning; Placenta; Pregnancy.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

There are no conflicts of interest to declare.

Figures

Figure 1.
Figure 1.
Maternal metabolism changes dynamically during gestation, in line with the metabolic demands of the growing fetus.
Figure 2.
Figure 2.
During pregnancy, there is a dynamic interplay between the placental production of hormones and changes in maternal metabolic physiology (influenced by genetics, environmental/nutritional factors and health) that govern the availability of nutrients to the growing fetus. Alterations in placental hormone production and maladaptations of maternal metabolism may result in pregnancy complications like gestational diabetes and abnormal fetal growth.

References

    1. Di Cianni G, Miccoli R, Volpe L, Lencioni C & Del Prato S. (2003) Intermediate metabolism in normal pregnancy and in gestational diabetes, Diabetes/metabolism research and reviews. 19, 259–70. - PubMed
    1. Ramos MP, Crespo-Solans MD, del Campo S, Cacho J & Herrera E. (2003) Fat accumulation in the rat during early pregnancy is modulated by enhanced insulin responsiveness, Am J Physiol Endocrinol Metab. 285, E318–28. - PubMed
    1. Catalano PM (2010) Obesity, insulin resistance, and pregnancy outcome, Reprod Suppl. 140, 365–71. - PMC - PubMed
    1. Musial B, Fernandez-Twinn DS, Vaughan OR, Ozanne SE, Voshol P, Sferruzzi-Perri AN & Fowden AL (2016) Proximity to delivery alters insulin sensitivity and glucose metabolism in pregnant mice, Diabetes. 65(4):851–60. - PMC - PubMed
    1. McIlvride S, Mushtaq A, Papacleovoulou G, Hurling C, Steel J, Jansen E, Abu-Hayyeh S & Williamson C. (2017) A progesterone-brown fat axis is involved in regulating fetal growth, Sci Rep. 7, 10671. - PMC - PubMed

Publication types